H. B. Fuller Company (NYSE:FUL) Receives Consensus Rating of “Moderate Buy” from Brokerages

H. B. Fuller Company (NYSE:FUL) has received an average rating of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $66.40.

Several equities research analysts have recently issued reports on FUL shares. Royal Bank Of Canada set a $58.00 price objective on shares of H. B. Fuller in a research note on Wednesday, May 27th. Citigroup raised their price objective on shares of H. B. Fuller from $67.00 to $70.00 and gave the stock a “buy” rating in a research note on Monday, March 30th. Vertical Research upgraded shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research note on Friday, March 27th. Wall Street Zen upgraded shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research note on Sunday, March 29th. Finally, UBS Group raised their price objective on shares of H. B. Fuller from $63.00 to $71.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 17th.

H. B. Fuller Trading Down 4.1%

Shares of FUL stock opened at $61.94 on Friday. H. B. Fuller has a 12 month low of $48.71 and a 12 month high of $68.63. The company has a quick ratio of 1.15, a current ratio of 1.92 and a debt-to-equity ratio of 1.01. The business’s 50 day moving average is $61.60 and its two-hundred day moving average is $61.28. The company has a market cap of $3.38 billion, a PE ratio of 20.44, a price-to-earnings-growth ratio of 0.85 and a beta of 0.96.

H. B. Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.37 by $0.04. H. B. Fuller had a return on equity of 12.29% and a net margin of 5.29%.The company had revenue of $950.27 million for the quarter, compared to the consensus estimate of $924.83 million. During the same quarter last year, the company posted $1.18 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. Equities analysts predict that H. B. Fuller will post 4.78 EPS for the current year.

H. B. Fuller Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were paid a $0.245 dividend. The ex-dividend date was Thursday, April 30th. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.24. This represents a $0.98 annualized dividend and a dividend yield of 1.6%. H. B. Fuller’s dividend payout ratio is 32.34%.

Insider Activity

In related news, CEO Celeste Beeks Mastin acquired 5,170 shares of the stock in a transaction dated Tuesday, April 7th. The shares were acquired at an average price of $57.08 per share, for a total transaction of $295,103.60. Following the completion of the purchase, the chief executive officer owned 8,670 shares in the company, valued at approximately $494,883.60. The trade was a 147.71% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.83% of the company’s stock.

Institutional Investors Weigh In On H. B. Fuller

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Bleakley Financial Group LLC grew its stake in shares of H. B. Fuller by 1.5% in the fourth quarter. Bleakley Financial Group LLC now owns 11,687 shares of the specialty chemicals company’s stock worth $695,000 after acquiring an additional 168 shares during the last quarter. California State Teachers Retirement System lifted its position in H. B. Fuller by 0.3% in the second quarter. California State Teachers Retirement System now owns 50,486 shares of the specialty chemicals company’s stock worth $3,037,000 after purchasing an additional 173 shares during the period. Glenmede Investment Management LP lifted its position in H. B. Fuller by 3.9% in the third quarter. Glenmede Investment Management LP now owns 4,809 shares of the specialty chemicals company’s stock worth $285,000 after purchasing an additional 179 shares during the period. CIBC Asset Management Inc lifted its position in H. B. Fuller by 3.6% in the fourth quarter. CIBC Asset Management Inc now owns 5,273 shares of the specialty chemicals company’s stock worth $314,000 after purchasing an additional 185 shares during the period. Finally, Allworth Financial LP lifted its position in H. B. Fuller by 50.1% in the fourth quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company’s stock worth $34,000 after purchasing an additional 193 shares during the period. Institutional investors and hedge funds own 95.93% of the company’s stock.

Key Stories Impacting H. B. Fuller

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: H. B. Fuller reported Q2 adjusted EPS of $1.41, topping estimates of $1.37, on revenue of $950.3 million versus $924.8 million expected, with sales up 5.8% year over year. H.B. Fuller Reports Second Quarter 2026 Results
• Positive Sentiment: The company also raised its full-year EPS outlook to a range of $4.60 to $4.90, signaling management confidence in continued operational improvement. H.B. Fuller Reports Second Quarter 2026 Results
• Neutral Sentiment: Management highlighted stronger margins, with adjusted gross margin improving 200 basis points year over year, and said cash generation and portfolio strategy remain key priorities. H.B. Fuller Earnings Call: Growth, Cash and AMS Risk
• Negative Sentiment: Investors are weighing H. B. Fuller’s planned cash acquisition of Advanced Medical Solutions for about £715 million, a deal that appears to have triggered worries about capital allocation and execution risk. H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions
• Negative Sentiment: Activist investor Ancora publicly condemned the transaction as “reckless,” adding to shareholder opposition and contributing to the stock’s weakness. Ancora Condemns H.B. Fuller’s Decision to Ignore Shareholder Opposition…

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.